Nivolumab and ipilimumab – November 2015

Nivolumab, concentrate solution for infusion: 10 mg/mL, 1 x 4 mL vial, 10 mg/mL, 1 x 10 mL vial, Opdivo®, plus Ipilimumab, concentrate solution for infusion: 5 mg/mL, 1 x 40 mL vial, 5 mg/mL, 1 x 10 mL vial, Yervoy®, Bristol Myers Squibb